Bioceres Crop Solutions Corp.

Adjusted EBITDA 1

The company defines adjusted EBITDA 1 as net income/(loss) exclusive of financial income/(costs), income tax benefit/(expense), depreciation, amortization, share-based compensation, and one-time transactional expenses.

Management believes that adjusted EBITDA 1 provides useful supplemental information to investors about the company and its results. Adjusted EBITDA 1 is among the measures used by the management team to evaluate the company’s financial and operating performance and make day-to-day financial and operating decisions. In addition, adjusted EBITDA 1 and similarly titled measures are frequently used by competitors, rating agencies, securities analysts, investors and other parties to evaluate companies in the same industry. Management also believes that adjusted EBITDA 1 is helpful to investors because it provides additional information about trends in the company’s core operating performance prior to considering the impact of capital structure, depreciation, amortization and taxation on results. Adjusted EBITDA 1 should not be considered in isolation or as a substitute for other measures of financial performance reported in accordance with IFRS. Adjusted EBITDA 1 has limitations as an analytical tool, including:

• Adjusted EBITDA 1 does not reflect changes in, including cash requirements for working capital needs or contractual commitments.

• Adjusted EBITDA 1 does not reflect financial expenses, or the cash requirements to service interest or principal payments on indebtedness, or interest income or other financial income.

• Adjusted EBITDA 1 does not reflect income tax expense or the cash requirements to pay income taxes.

• Although depreciation and amortization are non-cash charges, the assets being depreciated or amortized often will need to be replaced in the future, and adjusted EBITDA 1 does not reflect any cash requirements for these replacements.

• Although share-based compensation is a non-cash charge, adjusted EBITDA 1 does not consider the potentially dilutive impact of share-based compensation; and

• Other companies may calculate adjusted EBITDA 1 and similarly titled measures differently, limiting its usefulness as a comparative measure.

The company compensates for the inherent limitations associated with using adjusted EBITDA 1 through disclosure of these limitations, presentation in the combined financial statements in accordance with IFRS and reconciliation of adjusted EBITDA 1 to the most directly comparable IFRS measure, income/(loss) for the period or year.